scholarly journals Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: Results of a multicenter phase II trial

2000 ◽  
Vol 12 (5) ◽  
pp. 651-660 ◽  
Author(s):  
Andrea G. Maier ◽  
Barbara Kersting-Sommerhoff ◽  
Jacques W.A.J. Reeders ◽  
Werner Judmaier ◽  
Arnd A. Annweiler ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Iron Oxide ◽  
Mr Imaging ◽  
Contrast Agent ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Superparamagnetic Iron Oxide ◽  
Double Contrast ◽  
Multicenter Phase

Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.

Radiology ◽  
1988 ◽  
Vol 168 (2) ◽  
pp. 297-301 ◽  
Author(s):  
D D Stark ◽  
R Weissleder ◽  
G Elizondo ◽  
P F Hahn ◽  
S Saini ◽  
...  
Keyword(s):  
Iron Oxide ◽  
Mr Imaging ◽  
Contrast Agent ◽  
Clinical Application ◽  
Superparamagnetic Iron Oxide

scholarly journals Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma

2005 ◽  
Vol 93 (1) ◽  
pp. 131-136 ◽  
Author(s):  
A Toma ◽  
E Otsuji ◽  
Y Kuriu ◽  
K Okamoto ◽  
D Ichikawa ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Iron Oxide ◽  
Mr Imaging ◽  
Contrast Agent ◽  
Rectal Carcinoma ◽  
Superparamagnetic Iron Oxide ◽  
Monoclonal Antibody A7
Sign in / Sign up

Export Citation Format

Share Document